<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03183986</url>
  </required_header>
  <id_info>
    <org_study_id>N-20160071</org_study_id>
    <nct_id>NCT03183986</nct_id>
  </id_info>
  <brief_title>Comparison of the Efficacy of Phototherapy Using Blue LED's With Wavelength 478 vs. 459 nm.</brief_title>
  <official_title>Comparison of the Efficacy of Phototherapy With Wavelength 478 vs. 459 nm for Treatment of Neonatal Jaundice Using Blue LED's.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Aalborg Universitetshospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Treatment of neonatal jaundice is phototherapy with blue light at wavelength about 460 nm and
      irradiance &gt; 30 uw/cm2/nm. Though, recent in vitro models have suggested that a wavelength of
      478 nm should be optimal in reducing total serum bilirubin. The aim of this study is
      therefore to compare the efficiency of phototherapy with light emitting diodes (LED's) of 478
      vs. 459 nm., respectively.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective randomised study of the efficacy of phototherapy. Inclusion criteria
      are gestational age &gt; 33 weeks and birth weight &gt; 1800 grams, uncomplicated neonatal
      jaundice. The infants should be treated with phototherapy in a cradle for 24 hours, which is
      routine standard of care. Exclusion criteria is haemolytic disease. Total serum bilirubin
      (TSB) is measured before and after 24 hours of phototherapy. The infants are enrolled and
      randomised consecutively by the neonatologist using sealed and opaque envelopes.

      Power calculation based on expected difference in decrease of TSB of 6% between the two
      groups and a significance level of 0.05, showed that 48 infants should be enrolled in each
      group.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2017</start_date>
  <completion_date type="Anticipated">July 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Infants are randomised to phototherapy with blue LED's with wavelength of 478 or 459 nm. The decrease of TSB between the groups is compared.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Decrease of total serum bilirubin</measure>
    <time_frame>24 hours of phototherapy</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Neonatal Jaundice</condition>
  <arm_group>
    <arm_group_label>Phototherapy 478 nm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The jaundiced neonates receives phototherapy with blue light from above at wavelength 478 nm. They are treated for 24 hours, which is standard treatment for neonatal jaundice.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Phototherapy 459 nm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The jaundiced neonates receives phototherapy with blue light from above at wavelength 459 nm. They are treated for 24 hours, which is standard treatment for neonatal jaundice.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Phototherapy</intervention_name>
    <description>Phototherapy for 24 hours.</description>
    <arm_group_label>Phototherapy 478 nm</arm_group_label>
    <arm_group_label>Phototherapy 459 nm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Indication for phototherapy with single light

          -  Gestational age &gt; 33 weeks

          -  Birth weight &gt; 1800 grams

          -  Should be treatable in a cradle

        Exclusion Criteria:

          -  Haemolytic disease

          -  Indication for double/triple phototherapy or exchange transfusion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>28 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mette Donneborg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aalborg Universitetshospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pernille K Vandborg, MD, PhD</last_name>
    <phone>+ 45 26131711</phone>
    <email>pervan@rm.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mette R Donneborg, MD</last_name>
    <phone>+ 45 22406344</phone>
    <email>mld@rn.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Neonatal department, Aalborg University Hospital</name>
      <address>
        <city>Aalborg</city>
        <zip>9000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mette Donneborg, MD</last_name>
      <phone>+45 22406344</phone>
      <email>mld@rn.dk</email>
    </contact>
    <contact_backup>
      <last_name>Finn Ebbesen, Professor, MD</last_name>
      <phone>+ 45 97663330</phone>
      <email>fe@rn.dk</email>
    </contact_backup>
    <investigator>
      <last_name>Mette Donneborg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pernille Vandborg, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Finn Ebbesen, DmSci</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <reference>
    <citation>Lamola AA. A Pharmacologic View of Phototherapy. Clin Perinatol. 2016 Jun;43(2):259-76. doi: 10.1016/j.clp.2016.01.004. Epub 2016 Feb 15. Review.</citation>
    <PMID>27235206</PMID>
  </reference>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 9, 2017</study_first_submitted>
  <study_first_submitted_qc>June 9, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 12, 2017</study_first_posted>
  <last_update_submitted>June 19, 2017</last_update_submitted>
  <last_update_submitted_qc>June 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Aarhus</investigator_affiliation>
    <investigator_full_name>Pernille Kure Vandborg</investigator_full_name>
    <investigator_title>Principal investigator, MD, PhD.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Jaundice</mesh_term>
    <mesh_term>Jaundice, Neonatal</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

